Quick Answer
Cullinan Therapeutics, Inc. reported Total Revenue of $0.00 for fiscal year 2022.
Cullinan Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2022 | $0.00 | -100.0% |
| 2021 | $18.94M | — |
| 2020 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $0.00 | — | — |
| June 30, 2022 | $0.00 | — | — |
| March 31, 2022 | $0.00 | -100.0% | — |
| September 30, 2021 | $0.00 | — | — |
| June 30, 2021 | $0.00 | — | -100.0% |
| March 31, 2021 | $18.94M | — | — |
- Cullinan Therapeutics, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Cullinan Therapeutics, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 9, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: